BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu Z, Wu L, Duan Y, Wang J, Zhou S, Li J, Chen K, Li J, Liu H. Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3′,2′:3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2′,3′:4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5′-monophosphate-activated protein kinase (AMPK). Bioorganic & Medicinal Chemistry 2018;26:2017-27. [DOI: 10.1016/j.bmc.2018.02.052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhao J, Yan C, Xi C, Wu C, Zhao J, Li F, Ding Y, Zhang R, Qi S, Li X, Liu C, Hou W, Chen H, Wang Y, Wu D, Chen K, Jiang H, Huang H, Liu H. Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial. Cell Metabolism 2022. [DOI: 10.1016/j.cmet.2022.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang L, Kong H, Jin M, Li X, Stoika R, Lin H, Liu K. Synthesis of disaccharide modified berberine derivatives and their anti-diabetic investigation in zebrafish using a fluorescence-based technology. Org Biomol Chem 2020;18:3563-74. [PMID: 32347284 DOI: 10.1039/d0ob00327a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
3 Sharma P, Singh S, Thakur V, Sharma N, Grewal AS. Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. Obesity Medicine 2021;23:100329. [DOI: 10.1016/j.obmed.2021.100329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Matouš P, Kadaník M, Timoracký M, Kuneš J, Maříková J, Růžička A, Kočovský P, Pour M. Nucleophile-assisted cyclization of β-propargylamino acrylic compounds catalyzed by gold(i): a rapid construction of multisubstituted tetrahydropyridines and their fused derivatives. Org Chem Front 2020;7:3356-3367. [DOI: 10.1039/d0qo00653j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu C, Xi C, Tong J, Zhao J, Jiang H, Wang J, Wang Y, Liu H. Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia. Acta Pharm Sin B 2019;9:1216-30. [PMID: 31867167 DOI: 10.1016/j.apsb.2019.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
6 Shinde SS, Laha S, Tiwari DK, Sridhar B, Likhar PR. A multi-component reaction for the synthesis of pyrido [1,2-b] isoquinoline derivatives via the [3 + 2] cycloaddition reaction between alkynes and in situ generated isoquinolinium ylides. Org Biomol Chem 2019;17:4121-8. [PMID: 30968921 DOI: 10.1039/c9ob00560a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mari G, Catalani S, Antonini E, De Crescentini L, Mantellini F, Santeusanio S, Lombardi P, Amicucci A, Battistelli S, Benedetti S, Palma F. Synthesis and biological evaluation of novel heteroring-annulated pyrrolino-tetrahydroberberine analogues as antioxidant agents. Bioorganic & Medicinal Chemistry 2018;26:5037-44. [DOI: 10.1016/j.bmc.2018.08.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]